181 related articles for article (PubMed ID: 32294507)
1. Paeoniflorin ameliorates antipsychotic-induced hyperprolactinemia in rats by attenuating impairment of the dopamine D2 receptor and TGF-β1 signaling pathways in the hypothalamus and pituitary.
Huang X; Ren L; Hou L; Fan H; Wang C; Wang C; Li Y
J Ethnopharmacol; 2020 Jul; 257():112862. PubMed ID: 32294507
[TBL] [Abstract][Full Text] [Related]
2. The ancient Chinese formula Longdan Xiegan Tang improves antipsychotic-induced hyperprolactinemia by repairing the hypothalamic and pituitary TGF-β1 signaling in rats.
Ren L; Liu W; Wang C; Yang Y; Huang X; Wang C; Li Y
J Ethnopharmacol; 2020 May; 254():112572. PubMed ID: 31940455
[TBL] [Abstract][Full Text] [Related]
3. Paeoniflorin and liquiritin, two major constituents in Chinese herbal formulas used to treat hyperprolactinemia-associated disorders, inhibits prolactin secretion in prolactinoma cells by different mechanisms.
Wei Y; La L; Wang L; Batey R; Wang C; Li Y
J Ethnopharmacol; 2017 May; 204():36-44. PubMed ID: 28396166
[TBL] [Abstract][Full Text] [Related]
4. The prolactin-release inhibitor paeoniflorin suppresses proliferation and induces apoptosis in prolactinoma cells via the mitochondria-dependent pathway.
Wei Y; Zhou X; Ren L; Wang C; Li Y
J Cell Biochem; 2018 Jul; 119(7):5704-5714. PubMed ID: 29388711
[TBL] [Abstract][Full Text] [Related]
5. Studies on the regulatory effect of Peony-Glycyrrhiza Decoction on prolactin hyperactivity and underlying mechanism in hyperprolactinemia rat model.
Wang D; Wang W; Zhou Y; Wang J; Jia D; Wong HK; Zhang ZJ
Neurosci Lett; 2015 Oct; 606():60-5. PubMed ID: 26297122
[TBL] [Abstract][Full Text] [Related]
6. Active and total transforming growth factor-β1 are differentially regulated by dopamine and estradiol in the pituitary.
Recouvreux MV; Guida MC; Rifkin DB; Becu-Villalobos D; Díaz-Torga G
Endocrinology; 2011 Jul; 152(7):2722-30. PubMed ID: 21521749
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in the pituitary transforming growth factor-β1 system: studies in a model of resistant prolactinomas.
Recouvreux MV; Lapyckyj L; Camilletti MA; Guida MC; Ornstein A; Rifkin DB; Becu-Villalobos D; Díaz-Torga G
Endocrinology; 2013 Nov; 154(11):4192-205. PubMed ID: 24008346
[TBL] [Abstract][Full Text] [Related]
9. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Mechanism of Action of Yiru Tiaojing Granule Against Hyperprolactinemia In Vitro and In Vivo.
Wei Y; Wang X; Yu Z; Zhou W; Wang L; Qin F; Wang C; Hou L
Planta Med; 2015 Sep; 81(14):1255-62. PubMed ID: 26252831
[TBL] [Abstract][Full Text] [Related]
11. Effects of dopamine d2 receptor agonists in a pituitary transplantation-induced hyperprolactinaemia/anovulation model in rats.
Moro M; Inada Y; Miyata H; Komatsu H; Kojima M; Tsujii H
Clin Exp Pharmacol Physiol; 2001 Aug; 28(8):651-8. PubMed ID: 11473532
[TBL] [Abstract][Full Text] [Related]
12. Coadministration of dextromethorphan during pregnancy and throughout lactation prevents morphine-induced hyperprolactinemia in female rats.
Wu LY; Huang EY; Tao PL
Fertil Steril; 2010 Mar; 93(5):1686-94. PubMed ID: 19324339
[TBL] [Abstract][Full Text] [Related]
13. Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia.
Iwata Y; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Plitman E; Chung JK; Mar W; Gerretsen P; Pollock BG; Mulsant BH; Rajji TK; Mamo DC; Graff-Guerrero A
J Clin Psychiatry; 2016 Dec; 77(12):e1557-e1563. PubMed ID: 28086010
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
Markianos M; Hatzimanolis J; Lykouras L
Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms for suckling-induced changes in expression of prolactin receptor in the hypothalamus of the lactating rat.
Pi X; Voogt JL
Brain Res; 2001 Feb; 891(1-2):197-205. PubMed ID: 11164823
[TBL] [Abstract][Full Text] [Related]
16. Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data.
Tsuboi T; Bies RR; Suzuki T; Mamo DC; Pollock BG; Graff-Guerrero A; Mimura M; Uchida H
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():178-82. PubMed ID: 23727135
[TBL] [Abstract][Full Text] [Related]
17. Effects of TGF-beta1 on prolactin synthesis and secretion: an in-vitro study.
Coya R; Alvarez CV; Perez F; Gianzo C; Diéguez C
J Neuroendocrinol; 1999 May; 11(5):351-60. PubMed ID: 10320562
[TBL] [Abstract][Full Text] [Related]
18. 18β-Glycyrrhetinic Acid, a Novel Naturally Derived Agent, Suppresses Prolactin Hyperactivity and Reduces Antipsychotic-Induced Hyperprolactinemia in In Vitro and In Vivo Models.
Wang D; Zhang Y; Wang C; Jia D; Cai G; Lu J; Wang D; Zhang ZJ
Neurochem Res; 2016 Sep; 41(9):2233-42. PubMed ID: 27161375
[TBL] [Abstract][Full Text] [Related]
19. Not only dopamine D2 receptors involved in Peony-Glycyrrhiza Decoction, an herbal preparation against antipsychotic-associated hyperprolactinemia.
Wang D; Wong HK; Zhang L; McAlonan GM; Wang XM; Sze SC; Feng YB; Zhang ZJ
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):332-8. PubMed ID: 22796279
[TBL] [Abstract][Full Text] [Related]
20. Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice.
Kelly MA; Rubinstein M; Asa SL; Zhang G; Saez C; Bunzow JR; Allen RG; Hnasko R; Ben-Jonathan N; Grandy DK; Low MJ
Neuron; 1997 Jul; 19(1):103-13. PubMed ID: 9247267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
